Physician profile
Michelle Sims
NPI 1255703922
$894.08
in general payments reported to CMS, 2019-2025
11 companies · $189 in 2025
The $189 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $17.66 · 2023: $199 · 2024: $488 · 2025: $189.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $876.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $876.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $310.95 | 2023-2025 | Relistor |
| Nevro Corp. | $276.88 | 2023-2024 | Senza |
| Tersera Therapeutics LLC | $44.91 | 2024 | Prialt |
| Collegium Pharmaceutical, INC. | $44.19 | 2024 | Belbuca |
| Abbvie INC. | $42.71 | 2024 | |
| Valinor Pharma, LLC | $41.99 | 2025 | Movantik |
| Medtronic, INC. | $40.85 | 2024-2025 | Synchromedii |
| Globus Medical, INC. | $32.32 | 2025 | Senza |
| Boston Scientific Corporation | $27.00 | 2024 | Wavewriter Alpha Prime 16 |
| Abbott Laboratories | $17.66 | 2021 | |
| Scilex Pharmaceuticals INC. | $14.62 | 2023 | Ztlido |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Sims listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.